Catalyst OrthoScience
Naples, US · Founded 2014 · Delaware corporation · 3 known investors
Catalyst OrthoScience develops medical devices and surgical techniques for shoulder replacement procedures, including total shoulder replacements and reverse shoulder arthroplasty. The company serves orthopedic surgeons and hospitals aiming to improve patient outcomes and surgical efficiency.
Founders & leadership
SG
Steven GoldbergFounder & MD
CO
Carl O'ConnellChief Executive Officer
AA
Amy AblesVice President of Customer Engagement and Sales Excellence
E
EphraimChief Technology Officer
RR
Robert RichterChief Financial Officer
DT
Debbie TotahVice President of Human Resources
DD
Dale DavisonSenior Vice President of Manufacturing and Product Development
DS
Derace SchafferDirector
DF
Dan FlemingDirector
CM
Carter McNabbDirector
SH
Stephen HerringtonExecutive Officer
DW
David WoodDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$4.1MraisedJul 2025 · 3 investors · OtherRule 506(b)
▶$4.1MraisedJul 2025 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Wayne WallaceDirector
- Derace SchafferDirector
- Dan FlemingDirector
- Carl O'ConnellExecutive Officer, Director
- Carter McNabbDirector
- Offering amount
- $6M
- Amount sold
- $4.1M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedApr 2024 · 2 investors · OtherRule 506(b)
▶$1.5MraisedApr 2024 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Wayne WallaceDirector
- Steven S. GoldbergDirector
- Cameron RubinoDirector
- Dan FlemingDirector
- Carter McNabbDirector
- Carl O'ConnellExecutive Officer, Director
- Derace SchafferDirector
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.4MraisedSep 2023 · 81 investors · OtherRule 506(b)
▶$15.4MraisedSep 2023 · 81 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Wayne WallaceDirector
- Derace SchafferDirector
- Carter McNabbDirector
- Carl O'ConnellExecutive Officer, Director
- Steven GoldbergDirector
- Offering amount
- $15.4M
- Amount sold
- $15.4M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedNov 2017 · 26 investors · BiotechnologyRule 506(c)
▶$3.6MraisedNov 2017 · 26 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- David WoodDirector
- Steven S GoldbergDirector
- Robert KaufmanExecutive Officer, Director
- Derace L SchafferDirector
- Offering amount
- $4M
- Amount sold
- $3.6M
- Minimum investment
- $10K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$2.6MraisedAug 2016 · 7 investors · Other Health CareRule 506(b)
▶$2.6MraisedAug 2016 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen M HerringtonExecutive Officer, Director
- Derace L SchafferDirector
- Steven S GoldbergDirector
- David WoodDirector
- Robert KaufmanDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- Minimum investment
- $10K
- Proceeds to insiders
- $80K
- First sale
- Aug 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$50KraisedDec 2015 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedDec 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen HerringtonExecutive Officer
- Steven GoldbergPromoter
- Offering amount
- $1.3M
- Amount sold
- $50K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$50KraisedDec 2015 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedDec 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven GoldbergPromoter
- Stephen HerringtonExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $50K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Ohio firms lead $15M investment in Naples medical tech company | Business Observerbusinessobserverfl.com · 2025
- Catalyst OrthoScience Secures $15.0 Million in Growth Financingbusinesswire.com · 2025
- Catalyst OrthoScience secures $20m fundingfinance.yahoo.com · 2024
- Naples medical device firm picks up $20M in funding | Business Observerbusinessobserverfl.com · 2024
- Catalyst OrthoScience Raises $12.7 Millionryortho.com · 2019
- Catalyst OrthoScience raises $13m for total shoulder replacement - MassDevicemassdevice.com · 2019